399 related articles for article (PubMed ID: 29434214)
1. Mesenchymal stromal cells inhibit NLRP3 inflammasome activation in a model of Coxsackievirus B3-induced inflammatory cardiomyopathy.
Miteva K; Pappritz K; Sosnowski M; El-Shafeey M; Müller I; Dong F; Savvatis K; Ringe J; Tschöpe C; Van Linthout S
Sci Rep; 2018 Feb; 8(1):2820. PubMed ID: 29434214
[TBL] [Abstract][Full Text] [Related]
2. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
3. Involvement of NLRP3 inflammasome in CVB3-induced viral myocarditis.
Wang Y; Gao B; Xiong S
Am J Physiol Heart Circ Physiol; 2014 Nov; 307(10):H1438-47. PubMed ID: 25260607
[TBL] [Abstract][Full Text] [Related]
4. Colchicine prevents disease progression in viral myocarditis via modulating the NLRP3 inflammasome in the cardiosplenic axis.
Pappritz K; Lin J; El-Shafeey M; Fechner H; Kühl U; Alogna A; Spillmann F; Elsanhoury A; Schulz R; Tschöpe C; Van Linthout S
ESC Heart Fail; 2022 Apr; 9(2):925-941. PubMed ID: 35178861
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis.
Miteva K; Pappritz K; El-Shafeey M; Dong F; Ringe J; Tschöpe C; Van Linthout S
Stem Cells Transl Med; 2017 Apr; 6(4):1249-1261. PubMed ID: 28186704
[TBL] [Abstract][Full Text] [Related]
6. Sendai Virus V Protein Inhibits the Secretion of Interleukin-1β by Preventing NLRP3 Inflammasome Assembly.
Komatsu T; Tanaka Y; Kitagawa Y; Koide N; Naiki Y; Morita N; Gotoh B; Yokochi T
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021903
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of microRNA-15 protects H9c2 cells against CVB3-induced myocardial injury by targeting NLRX1 to regulate the NLRP3 inflammasome.
Tong R; Jia T; Shi R; Yan F
Cell Mol Biol Lett; 2020; 25():6. PubMed ID: 32099552
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis.
Liu X; Li M; Chen Z; Yu Y; Shi H; Yu Y; Wang Y; Chen R; Ge J
Basic Res Cardiol; 2022 Aug; 117(1):40. PubMed ID: 35997820
[TBL] [Abstract][Full Text] [Related]
9. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.
Yeon SH; Yang G; Lee HE; Lee JY
J Leukoc Biol; 2017 Jan; 101(1):205-215. PubMed ID: 27256568
[TBL] [Abstract][Full Text] [Related]
10. Macrophage NLRP3 inflammasome activated by CVB3 capsid proteins contributes to the development of viral myocarditis.
Bao J; Sun T; Yue Y; Xiong S
Mol Immunol; 2019 Oct; 114():41-48. PubMed ID: 31336248
[TBL] [Abstract][Full Text] [Related]
11. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1β.
Bracey NA; Beck PL; Muruve DA; Hirota SA; Guo J; Jabagi H; Wright JR; Macdonald JA; Lees-Miller JP; Roach D; Semeniuk LM; Duff HJ
Exp Physiol; 2013 Feb; 98(2):462-72. PubMed ID: 22848083
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
14. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
[TBL] [Abstract][Full Text] [Related]
15. The Severity of CVB3-Induced Myocarditis Can Be Improved by Blocking the Orchestration of NLRP3 and Th17 in Balb/c Mice.
Chen J; Yang F; Shi S; Liu X; Qin F; Wei X; Huang Y; Liang W; Miao L
Mediators Inflamm; 2021; 2021():5551578. PubMed ID: 34093086
[TBL] [Abstract][Full Text] [Related]
16. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
17. Crucial role of NLRP3 inflammasome in a murine model of Kawasaki disease.
Anzai F; Watanabe S; Kimura H; Kamata R; Karasawa T; Komada T; Nakamura J; Nagi-Miura N; Ohno N; Takeishi Y; Takahashi M
J Mol Cell Cardiol; 2020 Jan; 138():185-196. PubMed ID: 31836541
[TBL] [Abstract][Full Text] [Related]
18. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Gan W; Ren J; Li T; Lv S; Li C; Liu Z; Yang M
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):1-10. PubMed ID: 28986310
[TBL] [Abstract][Full Text] [Related]
19. OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation.
Marchetti C; Swartzwelter B; Gamboni F; Neff CP; Richter K; Azam T; Carta S; Tengesdal I; Nemkov T; D'Alessandro A; Henry C; Jones GS; Goodrich SA; St Laurent JP; Jones TM; Scribner CL; Barrow RB; Altman RD; Skouras DB; Gattorno M; Grau V; Janciauskiene S; Rubartelli A; Joosten LAB; Dinarello CA
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):E1530-E1539. PubMed ID: 29378952
[TBL] [Abstract][Full Text] [Related]
20. The cardiac glycoside ouabain activates NLRP3 inflammasomes and promotes cardiac inflammation and dysfunction.
Kobayashi M; Usui-Kawanishi F; Karasawa T; Kimura H; Watanabe S; Mise N; Kayama F; Kasahara T; Hasebe N; Takahashi M
PLoS One; 2017; 12(5):e0176676. PubMed ID: 28493895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
